NCT07446465 2026-03-03
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Phase 4 Not yet recruiting
Clinical Trials
22 trialsNCT07094893 2026-01-14
ARIEL-ENGIC
Gruppo Oncologico del Nord-Ovest
Phase 4 Not yet recruiting
NCT06461442 2025-12-05
Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
University of California, Davis
Phase 4 Enrolling by invitation
NCT02688803 2025-12-04
OTT15-04
Ottawa Hospital Research Institute
Phase 4 Terminated
NCT07158164 2025-11-13
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Rutgers, The State University of New Jersey
Phase 4 Recruiting
NCT02366819 2025-06-13
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
Phase 4 Recruiting
NCT06499415 2025-05-11
CALM
Maastricht University Medical Center
Phase 4 Recruiting
NCT03909646 2025-05-06
BOWTIE
Maastricht University Medical Center
Phase 4 Completed
NCT02484677 2023-05-26
5-FU
Assistance Publique Hopitaux De Marseille
Phase 4 Completed
NCT04875026 2022-09-19
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
Pierre Fabre Medicament
Phase 4 Completed
NCT02015650 2020-05-18
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Medical University Innsbruck
Phase 4 Terminated
NCT04269369 2020-02-13
Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients
Jessa Hospital
Phase 4 Unknown
NCT01271582 2019-01-29
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients
Asan Medical Center
Phase 4 Unknown
NCT00696488 2018-09-10
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
Wake Forest University Health Sciences
Phase 4 Completed
NCT02281682 2017-10-30
Akti
Maastricht University Medical Center
Phase 4 Unknown
NCT03084809 2017-03-21
Chemotherapy Combined With CIK Treating Colon Cancer
China Meitan General Hospital
Phase 4 Completed
NCT01641458 2016-02-02
FLOXTOX2
Cantonal Hospital of St. Gallen
Phase 4 Completed
NCT02284529 2014-11-06
Oxaliplatin
Sinphar Pharmaceutical Co., Ltd
Phase 4 Completed
NCT01972503 2013-12-11
Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer
Fudan University
Phase 4 Unknown
NCT01849380 2013-05-08
Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer
Shandong University
Phase 4 Unknown
NCT00138060 2010-07-20
Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants
Institut de Recherche Clinique sur les Cancers et le Sang
Phase 4 Completed
NCT01023633 2009-12-02
OPTIMOX1 in Chinese mCRC Patients
Nanjing Medical University
Phase 4 Unknown